{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Warren",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "85224",
      "recalling_firm": "Glaxosmithkline Consumer Healthcare Holdings",
      "address_1": "184 Liberty Corner Rd",
      "address_2": "N/A",
      "postal_code": "07059-6796",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Product was distributed throughout the United States, including Puerto Rico.",
      "recall_number": "D-1069-2020",
      "product_description": "Advil Liqui-Gel Mini 160+20+20 CT (e-commerce)  NDC # 0573-1715-59  SKU# F00573171559 (original lot # R53074)  Co-packaged Batch/Lot # 0198FR & 3188FRB",
      "product_quantity": "4,104 bottles",
      "reason_for_recall": "Labeling: Lacks Warning or Rx Legend- Certain lots does not include required safety warning information in the Drug Facts Panel.",
      "recall_initiation_date": "20200316",
      "center_classification_date": "20200326",
      "termination_date": "20211028",
      "report_date": "20200401",
      "code_info": "Batch/Lot #   Lot # 0198FR, original lot # R53074, exp. date 10/31/2020  Lot # 3188FRB, original lot # R53074, exp. date 10/31/2020",
      "more_code_info": ""
    }
  ]
}